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Abstract: Background: Granular Cell Tumors (GCT) are rare benign neoplasms with an estimated prevalence of 
0,4% in retrospective series. About 8% of GCT are located in the gastrointestinal tract, having the esophagus as 
the main affected area. Malignancy was reported in 2-4% of cases and there are no well established treatment 
protocols. Case summary: It was present an oligo-symptomatic female patient with diagnosis of GCT presented on 
the endoscopy. Complementary investigation was based on endoscopic ultrasound (EUS). The treatment consisted 
of mucosectomy and endoscopic variceal ligation, evolving with a favorable outcome. Conclusion: Despite 
disagreement on protocols for treatment of GCT, mucosectomy appears to be an effective option. 
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Introduction 
 Granular Cell Tumors (GCTs) are benign 
neoplasms, derived from Schwann Cells located at the 
submucosa [1]. It’s real prevalence is unknown. 
However, a retrospective series showed that GCTs 
represent 0.4% of all esophageal benign tumours [2]. 
It is predicted that 8% of GCTs are located in the 
gastrointestinal segment, with ⅔ of cases presented 
on the esophagus. Moreover, the malignancy rate is 
estimated at 2-4% [3]. 
Series and case reports describe the lesion as 
an incidental find in upper gastrointestinal endoscopies 
prescribed for other diagnostic hypotheses [2]. In 
addition, it is discussed the etiopathogenesis of the 
disease, as well as diagnostic methods and differences 
on the therapeutic approaches benign tumours [4]. 
Although, there are no well-established treatment 
protocols benign tumours [2].  
The present case report consists of a case of a 
patient with dyspeptic complaints, diagnosed with 
GCT. Furthermore, a review of the literature on 
etiopathogenesis, diagnostic investigation, treatment 
and management of this type of neoplasm. 
 
Methods 
The present study is a case report whose 
bibliographic research used the descriptors (MeSH 
Terms) Granular cell tumor. Esophagus. Benign 
neoplasm. Endoscopic mucosal resection. The research 
was carried out through the study of digital articles 
and virtual books attached to the PubMed, Embase, 
Ovid, Cochrane Library, Web Of Science, ScienceDirect 
Journals, Scopus, academic Google, in database 
platforms such as Scientific Electronic Library Online 
(SCIELO), PubMed, and in scientific repositories, 
following the rules of systematic review – PRISMA. 
Transparent reporting of systematic reviews and meta-
analyzes, Available in: https://www.prisma-
statement.org/. Accessed on 12/23/2020. Used as the 
main data sources, the most relevant works were 
selected for the theme for synthesis and presentation 
of information, excluding references that diverged 
from the purposes covered here. 
 
Case Report 
The present study was elaborated according to 
the rules of CARE case report. Available in: 
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Patient Information 
Female, 49 years old, unemployed. Came to 
our service to perform diagnostic endoscopy and 
colonoscopy due to intermittent bloating and 
postprandial regurgitation. Personal history of 
hypertension and diabetes mellitus and no (significant) 
family history. No previous abdominal surgery. 
 
Clinical Findings 
Physical examination without particularities, 
except for being overweight. 
 
Timeline 
The patient looks for assistance due to 
intermittent postprandial bloating and regurgitation, 
without relieving factors. The symptoms had started a 
month ago and were accompanied by nausea and 
early satiety. Other signs and symptoms, such as 




Laboratory test results showed no significant 
abnormality: Hb 124 g/L, Hct 35%, WBC 8.6 x 
109/mm3, Platelets 230 x 109/mm3, PT 37.8, INR 1.1 
and PTT 26.3 s.  An upper gastrointestinal endoscopy 
was performed, which showed a yellowish-white 
nodular lesion with subepithelial appearance and 
fibroelastic consistency at the distal esophagus, 
measuring approximately 6mm (Figure 1). 
Colonoscopy identified a sessile polyp in the ascending 
colon. Biopsies of the esophageal lesion and colonic 
polyp were performed, revealing a tumor of granular 
esophageal cells (Figure 2) and low-grade tubular 
adenoma, respectively. 
Figure 1 Echoendoscopic image of the granular cell 
tumor. 
Figure 2 Histopathological image of the granular cell 
tumor. 
In a joint decision between the patient and 
medical team, we opted for resecting the esophageal 
lesion. In consequence, a complementary exam for its 
staging was requested in another institution, due to 
unavailability in our service. The diagnosis of 
subepithelial lesion was confirmed with the 
echoendoscopy. The lesion was described as oval, 
hypoechoic, homogeneous, of approximately 5.6 mm x 
1.6 mm, with precise limits and regular contours. 
Inserted in the deep mucosa, it had a discrete layer 
rejection in the submucosa and there was no evidence 
of impairment of regional lymph nodes. Whereas it 
was a small lesion, benign in nature, with no invasion 




It was chosen for the endoscopic 
mucosectomy with the aid of an elastic band under 
sedation. A frontal view endoscope and a single 
channel made it possible to identify the lesion in the 
distal third of the esophagus. Followed by the use of 
an elastic band, which was triggered involving the 
entire lesion and the resection, made with a diathermic 
loop in Blend 1 mode/power of 30W. The piece was 
then captured with the same gripping and 
externalization loop throughout the mouth, which 
revealed to be free of macroscopic lateral margins. 
Proton Pump Inhibitor (Omeprazole 40mg/day) 
was prescribed for daily use along with symptomatics 
as needed. The patient was discharged on the same 
day. The submucosal injection of saline solution was 
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not necessary once the capture of the lesion with free 
margins using the elastic band kit was successful 
(Supplementary Video https://youtu.be/j09aK6Iyy08). 
 
Follow-up and Outcomes 
One month after the intervention, the patient 
remained asymptomatic. The anatomopathological 
study confirmed the diagnosis of granular cell tumor 
located in the submucosa. The tumor consisted of 
uniform cells of abundant and granular eosinophilic 
cytoplasm, with small nuclei and homogeneous 
chromatin. Furthermore, the lesion presented with free 
lateral and deep margins, affirming the absence of 
malignancy. The procedure used, although complex, 
when performed by experienced practitioners has a 
great tolerance for patients due to its low-invasive 




The tumor diagnosis initially caused a negative 
impression of the clinical picture even more in a 
patient with an anxious profile, however, the 
endoscopy team explained Initially the tumor diagnosis 
caused a negative impression in the prognosis, 
especially in a patient with an anxious profile. 
However, the endoscopy team explained in detail all 
the therapeutic options, as well as the need for 
complementary diagnosis with an exam not available 
in the present institution. 
All decisions were made by mutual agreement, 
respecting the patient's autonomy and the resection 
was performed without complications. The follow-up 
was made by telephone contact and she was satisfied 
with the result. 
 
Discussion and Literature Revision 
The patient is within the epidemiological group 
most affected by esophageal granular cell tumors and 
the diagnosis, as pointed out by the literature, was 
made accidentally.  It is known that, although small, 
there is a risk of growth and malignancy development 
[1]. In addition, it is evident the difficulty of carrying 
out highly complex tests through the public health 
system in the present country, as well as the obstacles 
concerning the follow-up of those cases. Thus, in 
accordance with the patient’s will, we opted for the 
endoscopic resection. Granular cell tumor (GCT) is a 
rare type of tumor. Its character of insidious onset 
sometimes leads to negligence or wrong diagnosis of 
the disease.  
GCTs were first described by Abrikossoff in 
1926. He reported this type of lesion in different parts 
of the body, most commonly in the oral cavity, skin 
and subcutaneous tissue, and less frequently affecting 
the breasts, thyroid, respiratory tract, biliary segment, 
female genital tract, nervous system and the 
gastrointestinal tract as a whole [1]. Approximately 8% 
of GCTs develop in the gastrointestinal tract, regularly 
in the esophagus, involved in one to two thirds of the 
cases [2-4]. Esophageal GCTs more commonly affect 
the distal esophagus. Was reported that most of the 
GCTs were found in the distal esophagus (⅔), and only 
20% and 15% in the middle and proximal esophagus, 
respectively [5]. The esophagus, GCTs are usually 
found incidentally during diagnostic endoscopy exams. 
It appears as a small nodule or plaque with a gray-
white to yellowish color [6]. It is also generally 
restricted to the submucosal layer of the esophagus. 
However, it was found that only 26% of patients have 
this typical aspect [7]. The esophageal GCTs can also 
be present as red or gray-white. Rarely, ulcerated 
tumors are seen on the mucosal surface. The most 
widely accepted theory is that it has a neurogenic 
origin, derived from Schwann cells, component of the 
submucosal neural plexus in the esophagus. A 
malignant potential has been reported in 2 to 4% of 
cases, which increases with the tumor size [3].  
GCTs are predominant in females and occur 
mainly during middle age, matching the patient’s 
profile. Patients with lesions smaller than 2 cm are 
more likely to be asymptomatic. If symptomatic, they 
may show symptoms that mimic gastroesophageal 
reflux disease. These tumors are usually found 
incidentally during EGD [8].  
EUS is the best procedure for assessing upper 
gastrointestinal submucosal lesions. It should be 
performed on all patients with the diagnosis of 
esophageal GCT, as the size of the tumor and the 
degree of invasion are important to define the 
treatment method [8]. EUS and endoscopic features 
together can distinguish GCT from lipomas, esophageal 
cysts and inflammatory polyps. Typical ultrasound 
characteristics were observed in 95-100% of cases, 
and histopathology confirmed the diagnosis of GCT for 
all 21 lesions after their removal [9]. In another study, 
it was found that the EUS identified 13 of the 14 cases 
of GCT before being confirmed histologically. These 
studies highlight the importance of EUS in the 
diagnosis of esophageal GCT [10].  
Biopsy with standard forceps is sufficient to 
achieve the diagnosis in 50-83% of cases [1,11]. 
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Endoscopic mucosal resection (EMR), EUS-guided 
biopsy and EUS-guided fine needle aspiration can also 
be used. By endoscopy and EUS, GCTs are difficult to 
distinguish from other submucosal tumors, for example 
leiomyomas or gastrointestinal stromal tumors. 
Therefore, histopathological analysis is essential [11]. 
A malignant potential has been reported in 2% 
to 4% of esophageal GCTs, especially if they are 
bigger than 1 cm [12]. The histological criteria for 
malignancy proposed by Fanburg-Smith are still 
debatable among pathologists, being metastasis the 
only malignancy criterion with unanimous agreement. 
Regarding GCTs with less than 1 cm, reports in the 
literature suggest conservative surveillance with 
endoscopy and EUS.  
In general, several potentially less invasive 
endoscopic approaches are available to address GCTs, 
including endoscopic band ligation and diathermy loop. 
In addition, EMR is also viable in cases confined to the 
mucosa [13].  
Others studies recommended the use of EMR 
for lesions with less than 2 cm in diameter; 
alternatively, endoscopic resection of the submucosal 
tunnel can be used for tumors with a diameter 
between 2 and 3 cm. Surgical removal with traditional 
open surgery or video-assisted thoracoscopic surgery 
was indicated for tumors with a high suspicion of 
malignancy, lesions originating from muscularis propria 
or, in some cases, with diameter between 2 and 3 cm 
[1,3]. Surgical removal with traditional open surgery or 
thoracoscopic surgery was recommended for tumors 
with a high suspicion of malignancy, tumors originating 
from the muscles themselves, or tumors larger than 3 
cm in diameter. The criteria suggested for EMR are 
Tumor size less than <2 cm, absence of connection to 
the muscle itself and no evidence of 
anatomopathological malignancy [9].   
These techniques can sometimes lead to 
unsatisfactory results, with incomplete or unclear 
resection status, especially in lesions that exceed the 
mucosa. As most GCTs show a submucosal 
manifestation, an ESD consists of an anatomically 
accurate resection method, once it performs a 
circumferential incision of the mucosa around the 
tumor, followed by the dissection of the submucosa 
[2]. Thus, with this approach, en bloc resection, a 
reliable histopathological diagnosis is more likely. In 
the case of a submucosal esophageal GCT, an ESD is 




As it was shown, in the present study, the 
patient is within the epidemiological group most 
affected by esophageal granular cell tumors. Her 
diagnosis was established with a diagnostic ultrasound 
exam and an EUS. The less conservative approach was 
justified by the limit of growth risk and malignant 
potential for injury, in addition to the limitations of 
performing EDA series in the scope of the country’s 
public health system.  Regarding the treatment itself, it 
was decided to perform the EMR with the aid of elastic 
band, due to the small characteristic of the lesion (6 
mm) and the restriction to the mucosa, as viewed 
previously on the EUS. The procedure was carried out 
successfully, without complications, and a sample was 
sent for anatomopathological study, confirming the 
accuracy of the diagnosis. 
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